[(3S,4R,5S)-3-benzamido-4-benzoyloxy-5-formyl-2-oxooxolan-3-yl]methyl benzoate
C27H21NO8 — CID 15222721
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S,4R,5S)-3-benzamido-4-benzoyloxy-5-formyl-2-oxooxolan-3-yl]methyl benzoate
[(3S,4R,5S)-3-benzamido-4-benzoyloxy-5-formyl-2-oxooxolan-3-yl]methyl benzoate (PubChem CID 15222721) has the molecular formula C27H21NO8 and a molecular weight of 487.46 g/mol. Its IUPAC name is [(3S,4R,5S)-3-benzamido-4-benzoyloxy-5-formyl-2-oxooxolan-3-yl]methyl benzoate.
Molecular Properties
| Compound Name | [(3S,4R,5S)-3-benzamido-4-benzoyloxy-5-formyl-2-oxooxolan-3-yl]methyl benzoate |
|---|---|
| PubChem CID | 15222721 |
| Molecular Formula | C27H21NO8 |
| Molecular Weight | 487.46 g/mol |
| Exact Mass | 487.13 |
| IUPAC Name | [(3S,4R,5S)-3-benzamido-4-benzoyloxy-5-formyl-2-oxooxolan-3-yl]methyl benzoate |
| SMILES | O=C[C@H]1OC(=O)[C@@](COC(=O)c2ccccc2)(NC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1 |
| InChI | InChI=1S/C27H21NO8/c29-16-21-22(36-25(32)20-14-8-3-9-15-20)27(26(33)35-21,28-23(30)18-10-4-1-5-11-18)17-34-24(31)19-12-6-2-7-13-19/h1-16,21-22H,17H2,(H,28,30)/t21-,22+,27+/m1/s1 |
| InChIKey | WWRAICUEMHWVED-VHSZZVNMSA-N |
| XLogP | 2.36 |
| TPSA | 125.07 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 487.46 |
| LogP ≤ 5 | 2.36 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15222721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.